The fight for affordable insulin
Insulin was the poster child of overpriced life saving drugs, but a manufacturer finally capped the cost at $35. Vox’s Dylan Scott explains how pharmaceutical companies for decades managed to overprice drugs Americans desperately needed.
This episode was produced by Haleema Shah, edited by Amina Al-Sadi, fact-checked by Laura Bullard and Matt Collette, engineered by Patrick Boyd, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices